Therefore, a more thorough investigation of the expression and/or activation levels of NLRP3 inflammasome-associated components, namely, ASC, Caspase-1, and effector cytokines IL-1β and IL-18, is warranted in human GC patient samples. This evidence concerns the gene CASP1 and gastric cancer.